Venture investors still love drug developers

cafead

Administrator
Staff member
  • cafead   Jul 06, 2021 at 10:32: AM
via The second quarter was always going to struggle to match the $10bn raised in private financing rounds in the first three months of the year. So while $5bn looks like a substantial pullback, it is far from a real retrenchment.

article source